Global Nanotechnology Drug Delivery Systems Market Growth, Trends, and Forecasts 2015-2025

Global Nanotechnology Drug Delivery Systems Market Growth, Trends, and Forecasts 2015-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Nanotechnology Drug Delivery Systems will have significant change from previous year. By the most conservative estimates of global Nanotechnology Drug Delivery Systems market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Nanotechnology Drug Delivery Systems market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Nanotechnology Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Nanotechnology Drug Delivery Systems, covering the supply chain analysis, impact assessment to the Nanotechnology Drug Delivery Systems market size growth rate in several scenarios, and the measures to be undertaken by Nanotechnology Drug Delivery Systems companies in response to the COVID-19 epidemic.

Segmentation by product type:
Nanocrystals
Nanoparticles
Dendrimers
Gold Nanoparticles
Fullerenes
Liposomes
Nanotubes
Others

Segmentation by Application
Immunology
Cardiovascular
Neurology
Oncology
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
Rest of Americas
APAC
China
Japan
Korea
Taiwan
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Rest of APAC
Europe
Germany
France
UK
Russia
Italy
Benelux
Nordic
Rest of Europe
MENA
Saudi Arabia
UAE
Turkey
South Africa
Egypt

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.
AbbVie, Inc.
3M
Amgen Inc.
Johnson & Johnson
Merck & Co., Inc.
Celgene Corporation
Pfizer, Inc.
Novartis International AG
Teva Pharmaceutical Industries Ltd.
Perrigo Company plc
Nitto
TheraJect
Microdermics
Zosano Pharma
Corium
Nanopass Technologies
Lohmann Therapie-Systeme AG
Valeritas
Becton-Dickinson(BD)Technologies
Vaxxas

Please note: The report will take approximately 2 business days to prepare and deliver.


1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Nanotechnology Drug Delivery Systems?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Nanotechnology Drug Delivery Systems Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 Market Overview
2.1.1 Global Nanotechnology Drug Delivery Systems Market Size and Forecast, 2015-2025
2.1.2 Nanotechnology Drug Delivery Systems Market Size and Forecast by Region, 2015 VS 2020 VS 2025
2.2 Global Nanotechnology Drug Delivery Systems Market Size and Forecast by Regions, 2015-2025 ($ millions)
2.3 Americas Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
2.4 APAC Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
2.5 Europe Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
2.6 MENA Nanotechnology Drug Delivery Systems Market Size YoY Growth, 2015-2025 ($ millions)
3 Nanotechnology Drug Delivery Systems Market Size by Player
3.1 Global Nanotechnology Drug Delivery Systems Market Size by Player
3.1.1 Global Top Players Nanotechnology Drug Delivery Systems Revenue, 2018-2020E ($ millions)
3.1.2 Global Top Nanotechnology Drug Delivery Systems Players Market Share, 2018-2020E
3.2 Global Key Nanotechnology Drug Delivery Systems Players Rank in 2019
3.3 Global Key Nanotechnology Drug Delivery Systems Players Head office and Products Offered
3.4 Market Concentration Rate Analysis
3.4.1 Competition Landscape Analysis
3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2018-2020E
3.5 New Products and Potential Entrants
3.6 Mergers & Acquisitions, Expansion
4 Nanotechnology Drug Delivery Systems Segment by Type
4.1 Overview
4.1.1 Nanocrystals
4.1.2 Nanoparticles
4.1.3 Dendrimers
4.1.4 Gold Nanoparticles
4.1.5 Fullerenes
4.1.6 Liposomes
4.1.7 Nanotubes
4.1.8 Others
4.2 Global Nanotechnology Drug Delivery Systems Market Size by Type, 2015-2025 ($ millions)
4.3 Nanocrystals Market Size by Region, 2015-2025 ($ millions)
4.4 Nanoparticles Market Size by Region, 2015-2025 ($ millions)
4.5 Dendrimers Market Size by Region, 2015-2025 ($ millions)
4.6 Gold Nanoparticles Market Size by Region, 2015-2025 ($ millions)
4.7 Fullerenes Market Size by Region, 2015-2025 ($ millions)
4.8 Liposomes Market Size by Region, 2015-2025 ($ millions)
4.9 Nanotubes Market Size by Region, 2015-2025 ($ millions)
4.10 Others Market Size by Region, 2015-2025 ($ millions)
5 Nanotechnology Drug Delivery Systems Segment by Application
5.1 Overview
5.1.1 Immunology
5.1.2 Cardiovascular
5.1.3 Neurology
5.1.4 Oncology
5.1.5 Others
5.2 Global Nanotechnology Drug Delivery Systems Market Size by Application, 2015-2025 ($ millions)
5.3 Immunology Market Size by Region, 2015-2025 ($ millions)
5.4 Cardiovascular Market Size by Region, 2015-2025 ($ millions)
5.5 Neurology Market Size by Region, 2015-2025 ($ millions)
5.6 Oncology Market Size by Region, 2015-2025 ($ millions)
5.7 Others Market Size by Region, 2015-2025 ($ millions)
6 Americas
6.1 Americas Nanotechnology Drug Delivery Systems Market Size by Country
6.2 United States Nanotechnology Drug Delivery Systems Market Size
6.3 Canada Nanotechnology Drug Delivery Systems Market Size
6.4 Mexico Nanotechnology Drug Delivery Systems Market Size
6.5 Brazil Nanotechnology Drug Delivery Systems Market Size
7 APAC
7.1 APAC Nanotechnology Drug Delivery Systems Market Size by Regions
7.2 China Nanotechnology Drug Delivery Systems Market Size
7.3 Japan Nanotechnology Drug Delivery Systems Market Size
7.4 Korea Nanotechnology Drug Delivery Systems Market Size
7.5 Taiwan Nanotechnology Drug Delivery Systems Market Size
7.6 India Nanotechnology Drug Delivery Systems Market Size
7.7 Australia Nanotechnology Drug Delivery Systems Market Size
7.8 Indonesia Nanotechnology Drug Delivery Systems Market Size
7.9 Thailand Nanotechnology Drug Delivery Systems Market Size
7.10 Malaysia Nanotechnology Drug Delivery Systems Market Size
7.11 Philippines Nanotechnology Drug Delivery Systems Market Size
7.12 Vietnam Nanotechnology Drug Delivery Systems Market Size
8 Europe
8.1 Europe Nanotechnology Drug Delivery Systems by Country
8.2 Germany Nanotechnology Drug Delivery Systems Market Size
8.3 France Nanotechnology Drug Delivery Systems Market Size
8.4 UK Nanotechnology Drug Delivery Systems Market Size
8.5 Russia Nanotechnology Drug Delivery Systems Market Size
8.6 Italy Nanotechnology Drug Delivery Systems Market Size
8.7 Australia Nanotechnology Drug Delivery Systems Market Size
8.8 Benelux Nanotechnology Drug Delivery Systems Market Size
8.9 Nordic Nanotechnology Drug Delivery Systems Market Size
9 MENA
9.1 MENA & Africa Nanotechnology Drug Delivery Systems by Country
9.2 Saudi Arabia Nanotechnology Drug Delivery Systems Market Size
9.3 UAE Nanotechnology Drug Delivery Systems Market Size
9.4 Turkey Nanotechnology Drug Delivery Systems Market Size
9.5 South Africa Nanotechnology Drug Delivery Systems Market Size
9.6 Egypt Nanotechnology Drug Delivery Systems Market Size
10 Market Drivers, Challenges and Trends
10.1 Market Drivers and Impact
10.1.1 Growing Demand from Key Regions
10.1.2 Growing Demand from Key Applications and Potential Industries
10.2 Market Challenges and Impact
10.3 Market Trends
11 Key Players Analysis
11.1 AbbVie, Inc.
11.1.1 AbbVie, Inc. Company Information
11.1.2 AbbVie, Inc. Nanotechnology Drug Delivery Systems Product Offered
11.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.1.4 AbbVie, Inc. Main Business Overview
11.1.5 AbbVie, Inc. Latest Developments
11.2 3M
11.2.1 3M Company Information
11.2.2 3M Nanotechnology Drug Delivery Systems Product Offered
11.2.3 3M Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.2.4 3M Main Business Overview
11.2.5 3M Latest Developments
11.3 Amgen Inc.
11.3.1 Amgen Inc. Company Information
11.3.2 Amgen Inc. Nanotechnology Drug Delivery Systems Product Offered
11.3.3 Amgen Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.3.4 Amgen Inc. Main Business Overview
11.3.5 Amgen Inc. Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Nanotechnology Drug Delivery Systems Product Offered
11.4.3 Johnson & Johnson Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Information
11.5.2 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Product Offered
11.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.5.4 Merck & Co., Inc. Main Business Overview
11.5.5 Merck & Co., Inc. Latest Developments
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Information
11.6.2 Celgene Corporation Nanotechnology Drug Delivery Systems Product Offered
11.6.3 Celgene Corporation Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.6.4 Celgene Corporation Main Business Overview
11.6.5 Celgene Corporation Latest Developments
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Information
11.7.2 Pfizer, Inc. Nanotechnology Drug Delivery Systems Product Offered
11.7.3 Pfizer, Inc. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.7.4 Pfizer, Inc. Main Business Overview
11.7.5 Pfizer, Inc. Latest Developments
11.8 Novartis International AG
11.8.1 Novartis International AG Company Information
11.8.2 Novartis International AG Nanotechnology Drug Delivery Systems Product Offered
11.8.3 Novartis International AG Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.8.4 Novartis International AG Main Business Overview
11.8.5 Novartis International AG Latest Developments
11.9 Teva Pharmaceutical Industries Ltd.
11.9.1 Teva Pharmaceutical Industries Ltd. Company Information
11.9.2 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Product Offered
11.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.9.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.10 Perrigo Company plc
11.10.1 Perrigo Company plc Company Information
11.10.2 Perrigo Company plc Nanotechnology Drug Delivery Systems Product Offered
11.10.3 Perrigo Company plc Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.10.4 Perrigo Company plc Main Business Overview
11.10.5 Perrigo Company plc Latest Developments
11.11 Nitto
11.11.1 Nitto Company Information
11.11.2 Nitto Nanotechnology Drug Delivery Systems Product Offered
11.11.3 Nitto Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.11.4 Nitto Main Business Overview
11.11.5 Nitto Latest Developments
11.12 TheraJect
11.12.1 TheraJect Company Information
11.12.2 TheraJect Nanotechnology Drug Delivery Systems Product Offered
11.12.3 TheraJect Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.12.4 TheraJect Main Business Overview
11.12.5 TheraJect Latest Developments
11.13 Microdermics
11.13.1 Microdermics Company Information
11.13.2 Microdermics Nanotechnology Drug Delivery Systems Product Offered
11.13.3 Microdermics Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.13.4 Microdermics Main Business Overview
11.13.5 Microdermics Latest Developments
11.14 Zosano Pharma
11.14.1 Zosano Pharma Company Information
11.14.2 Zosano Pharma Nanotechnology Drug Delivery Systems Product Offered
11.14.3 Zosano Pharma Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.14.4 Zosano Pharma Main Business Overview
11.14.5 Zosano Pharma Latest Developments
11.15 Corium
11.15.1 Corium Company Information
11.15.2 Corium Nanotechnology Drug Delivery Systems Product Offered
11.15.3 Corium Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.15.4 Corium Main Business Overview
11.15.5 Corium Latest Developments
11.16 Nanopass Technologies
11.16.1 Nanopass Technologies Company Information
11.16.2 Nanopass Technologies Nanotechnology Drug Delivery Systems Product Offered
11.16.3 Nanopass Technologies Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.16.4 Nanopass Technologies Main Business Overview
11.16.5 Nanopass Technologies Latest Developments
11.17 Lohmann Therapie-Systeme AG
11.17.1 Lohmann Therapie-Systeme AG Company Information
11.17.2 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Product Offered
11.17.3 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.17.4 Lohmann Therapie-Systeme AG Main Business Overview
11.17.5 Lohmann Therapie-Systeme AG Latest Developments
11.18 Valeritas
11.18.1 Valeritas Company Information
11.18.2 Valeritas Nanotechnology Drug Delivery Systems Product Offered
11.18.3 Valeritas Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.18.4 Valeritas Main Business Overview
11.18.5 Valeritas Latest Developments
11.19 Becton-Dickinson(BD)Technologies
11.19.1 Becton-Dickinson(BD)Technologies Company Information
11.19.2 Becton-Dickinson(BD)Technologies Nanotechnology Drug Delivery Systems Product Offered
11.19.3 Becton-Dickinson(BD)Technologies Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.19.4 Becton-Dickinson(BD)Technologies Main Business Overview
11.19.5 Becton-Dickinson(BD)Technologies Latest Developments
11.20 Vaxxas
11.20.1 Vaxxas Company Information
11.20.2 Vaxxas Nanotechnology Drug Delivery Systems Product Offered
11.20.3 Vaxxas Nanotechnology Drug Delivery Systems Revenue and YoY Growth, 2018-2020E
11.20.4 Vaxxas Main Business Overview
11.20.5 Vaxxas Latest Developments
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook